nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—SCN5A—dilated cardiomyopathy	0.829	1	CbGaD
Hexylcaine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.05	0.461	CbGeAlD
Hexylcaine—SCN5A—endocardium—dilated cardiomyopathy	0.0258	0.238	CbGeAlD
Hexylcaine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0244	0.225	CbGeAlD
Hexylcaine—SCN3A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00548	0.0925	CbGpPWpGaD
Hexylcaine—SCN2A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00527	0.0888	CbGpPWpGaD
Hexylcaine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00508	0.0857	CbGpPWpGaD
Hexylcaine—SCN1A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00508	0.0857	CbGpPWpGaD
Hexylcaine—Cocaine—SCN5A—dilated cardiomyopathy	0.00265	1	CrCbGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.0022	0.0372	CbGpPWpGaD
Hexylcaine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00217	0.02	CbGeAlD
Hexylcaine—SCN3A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0021	0.0355	CbGpPWpGaD
Hexylcaine—SCN5A—myocardium—dilated cardiomyopathy	0.00204	0.0188	CbGeAlD
Hexylcaine—SCN2A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00202	0.0341	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.00196	0.0331	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00195	0.0329	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00195	0.0329	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.00167	0.0282	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.00167	0.0282	CbGpPWpGaD
Hexylcaine—SCN3A—heart—dilated cardiomyopathy	0.00143	0.0132	CbGeAlD
Hexylcaine—SCN5A—heart—dilated cardiomyopathy	0.00142	0.0131	CbGeAlD
Hexylcaine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.00122	0.0112	CbGeAlD
Hexylcaine—SCN3A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000795	0.0134	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000764	0.0129	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000749	0.0126	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000737	0.0124	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000737	0.0124	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000719	0.0121	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000694	0.0117	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000694	0.0117	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000662	0.0112	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000567	0.00957	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000555	0.00936	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000545	0.00919	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000533	0.00899	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000526	0.00887	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000526	0.00887	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000514	0.00867	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000514	0.00867	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000488	0.00822	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000446	0.00752	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000428	0.00723	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000413	0.00697	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000413	0.00697	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000361	0.0061	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000335	0.00565	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000322	0.00543	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000311	0.00524	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000311	0.00524	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00029	0.0049	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000258	0.00436	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000239	0.00403	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00023	0.00388	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000224	0.00378	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000222	0.00374	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000222	0.00374	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000218	0.00368	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00021	0.00354	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000203	0.00342	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000201	0.0034	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000195	0.00329	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000194	0.00328	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000194	0.00328	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000188	0.00317	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000188	0.00317	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	0.000169	0.00284	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	0.000162	0.00273	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000156	0.00263	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	0.000156	0.00263	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000156	0.00263	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00015	0.00252	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000144	0.00242	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000139	0.00234	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000139	0.00234	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000137	0.0023	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000132	0.00223	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	0.000128	0.00215	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	0.000123	0.00207	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	0.00012	0.00203	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	0.000118	0.00199	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	0.000118	0.00199	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000116	0.00195	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	0.000112	0.00189	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000111	0.00188	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000111	0.00188	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	0.00011	0.00185	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	0.000107	0.00181	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	0.000104	0.00175	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	0.000104	0.00175	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.74e-05	0.00164	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.53e-05	0.00144	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	8.31e-05	0.0014	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	7.97e-05	0.00135	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	7.83e-05	0.00132	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	7.66e-05	0.00129	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	7.66e-05	0.00129	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	7.39e-05	0.00125	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	7.39e-05	0.00125	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	7.36e-05	0.00124	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	7.28e-05	0.00123	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	7.1e-05	0.0012	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	7.1e-05	0.0012	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	5.47e-05	0.000922	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	5.25e-05	0.000886	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	5.21e-05	0.000878	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	5.19e-05	0.000876	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	5.07e-05	0.000855	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	5.07e-05	0.000855	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	5e-05	0.000844	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	4.99e-05	0.000842	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	4.82e-05	0.000814	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	4.82e-05	0.000814	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	3.56e-05	0.000601	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	3.39e-05	0.000572	CbGpPWpGaD
